Consequently, the aim of this study is to analyze the five-year incidence of urinary incontinence in breast cancer patients in consideration of age, co-diagnoses, and adjuvant endocrine therapy with tamoxifen or aromatase inhibitors. Here, CYP19A1 is linked to breast cancer.